Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Receivables - Other (2022)

Historic Receivables - Other for Kiniksa Pharmaceuticals International (KNSA) over the last 1 years, with Q4 2022 value amounting to $7.7 million.

  • Kiniksa Pharmaceuticals International's Receivables - Other changed N/A to $7.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $7.7 million, marking a year-over-year change of. This contributed to the annual value of $7.7 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Kiniksa Pharmaceuticals International reported Receivables - Other of $7.7 million as of Q4 2022.
  • Kiniksa Pharmaceuticals International's Receivables - Other's 5-year high stood at $7.7 million during Q4 2022, with a 5-year trough of $7.7 million in Q4 2022.